6
Oct
2026

Rentschler Biopharma SE

Exhibitor at CPHI Milan 2026 stand 12F62, Contract Manufacturing & Services
About Us

Rentschler Biopharma is a global leading contract development and manufacturing organization (CDMO) focused exclusively on client projects. The company offers process development and manufacturing of biopharmaceuticals, as well as related consulting activities, project management and regulatory support. Rentschler Biopharma is a family-owned company with about 1,400 employees, headquartered in Laupheim, Germany, with operations in Milford, MA, USA.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Germany
  • On CPHI since:
    2024
  • Certificates:
    3
  • Employees:
    1000 - 4999
Company types
Biopharmaceutical company
CMO/CDMO
Primary activities
API Producer
Biopharmaceutical
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 12F62, Contract Manufacturing & Services

Products Featured at CPHI Milan 2026

  • Our Rentschler Development Services - solutions tailored to you

    Product Our Rentschler Development Services - solutions tailored to you

    VelocityVelocity is our fast-track service offering for clients who must be fast. With our fixed timelines, fixed prices and standardized processes, we reliably deliver released Drug Substance for your clinical Phase I/II project on-time. 

    Flexibility
    Sometimes our clients require flexib...

Rentschler Biopharma SE Resources (1)

  • Taking off with the right CDMO

    Brochure Taking off with the right CDMO

    In the biopharmaceutical industry, companies face a complexjourney as they strive to transform groundbreaking ideas intolife-saving therapeutics. The process is fraught with challenges,also driven by current geopolitical changes, that demand for asuitable and reliable Contract Development and ManufacturingOrganization (CDMO) partner.